Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pills, injections
10:04am, Monday, 09'th Feb 2026
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker's new Wegovy obesity pill and injections in the U.S. CNBC'
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
10:00am, Monday, 09'th Feb 2026
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Stock Market Today: Major Indexes Mixed After Volatile Week; Dow Slips Back Below 50000
10:00am, Monday, 09'th Feb 2026
Major stock indexes were mixed in early trading Monday after ending a volatile week with sharp gains.
Hims & Hers Stops Selling Wegovy Copycat Weight-Loss Pill
09:49am, Monday, 09'th Feb 2026
Novo Nordisk A/S shares rose after Hims & Hers Health Inc. agreed to stop selling a copycat version of the new Wegovy weight-loss pill following US government threats to crack down on knockoffs. Bloom
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
09:46am, Monday, 09'th Feb 2026
Novo Nordisk A/S (NYSE: NVO) on Monday said it has filed a lawsuit against telehealth company Hims & Hers Inc. (NYSE: HIMS) for infringing U.S. Patent 8,129,343 with Hims' compounded semaglutide produ
Dr. Scott Gottlieb on Novo Nordisk vs. Hims & Hers: We have a drug approval process for a reason
09:27am, Monday, 09'th Feb 2026
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the fight between Novo Nordisk and Hims & Hers over GLP-1 drugs, immunization policies in the U.S., and more.
Hims & Hers scraps low-cost weight-loss pill following backlash
09:25am, Monday, 09'th Feb 2026
Hims & Hers scraps low-cost weight-loss pill following backlash Him & Hers (NYSE:HIMS) shares are set to open 23% lower at about $18 after the telehealth company announced over the weekend that it wil
First Look: Amazon's $200B Capex, Coinbase's SB Ad, Kroger CEO
07:38am, Monday, 09'th Feb 2026
Stock News Japan rally on election landslide: Japanese stocks hit record highs after Prime Minister Sanae Takaichi's coalition secured a two-thirds lower-house
Hims & Hers Pulls Compounded Weight-Loss Pill After FDA Warning
07:18am, Monday, 09'th Feb 2026
Hims and Hers Health Inc. (HIMS) shares remained volatile on Monday, as the company confirmed it has stopped offering its recently launched compounded oral weight
Novo Nordisk sues Hims & Hers over patent infringement
07:08am, Monday, 09'th Feb 2026
Novo Nordisk said on Monday it has filed a lawsuit against U.S. telehealth company Hims & Hers for infringing on the Danish group's patents.
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
07:00am, Monday, 09'th Feb 2026
Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the
Hims & Hers removes a knock-off weight loss drug days after introducing it
07:21pm, Saturday, 07'th Feb 2026
Hims & Hers introduced a once-a-day weight loss pill on Thursday. Then, on Saturday, the company said it would stop offering the pill to customers.
Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown
05:22pm, Saturday, 07'th Feb 2026
Hims & Hers backed down under FDA pressure two days just after launching the copycat version of Novo Nordisk's weight-loss pill.
Hims & Hers Health Stops Offering Wegovy Pill Knockoff Over FDA Crackdown
05:22pm, Saturday, 07'th Feb 2026
Hims & Hers backed down under FDA pressure two days just after launching the copycat version of Novo Nordisk's weight-loss pill.
Hims & Hers pulls copycat weight-loss pill after threats of legal action
03:46pm, Saturday, 07'th Feb 2026
Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened le
